Page last updated at 12:56 GMT, Friday, 7 November 2008

Japan's Daiichi in Ranbaxy deal

Pharmaceutical firms are facing rivalry from generic drug companies

Leading Japanese pharmaceutical firm Daiichi Sankyo has completed its $4.2bn (£2.6bn) takeover of the Indian drugs firm Ranbaxy.

The Japanese firm has bought a 63% stake in Ranbaxy, which is a leading manufacturer of generic drugs.

Daiichi Sankyo said it was determined to work with Ranbaxy to achieve "sustainable growth".

In September, US authorities banned the import of 30 of Ranbaxy's drugs, amid concerns over manufacturing standards.

The deal has come as pharmaceutical firms face stiff rivalry from generic drugs firms in developing nations.

Print Sponsor

Drug firm faces 'deception' claim
15 Jul 08 |  Business
Japan set for $4.6bn pharma deal
11 Jun 08 |  Business
Big Pharma defends patent power
22 Apr 08 |  Business

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Sign in

BBC navigation

Copyright © 2020 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific